Topic: BRAF V600E-specific immunohistochemistry reveals low mutation rates in

BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma.

http://www.ncbi.nlm.nih.gov/pubmed/24309328

"In addition, we demonstrate that VE1 immunohistochemistry is a feasible approach to routinely screen for BRAF V600E mutation in biliary tract cancer patients, thereby facilitating the detection of rare patients who may benefit from BRAF mutation-targeted therapies.Modern Pathology advance online publication, 6 December 2013; doi:10.1038/modpathol.2013.206."

Any advice or comments I give are based on personal experiences and knowledge and are my opinions only, they are not to be substituted for professional medical advice. Please seek professional advice from a qualified doctor or medical professional.

Re: BRAF V600E-specific immunohistochemistry reveals low mutation rates in

Gene mutation tests are one important tool in identifying possible treatment plans.  Some medical centers include this test automatically, others do not.   Patients should bring this to the attention of the physician.
Hugs,
Marion

THIS INFORMATION IS NOT INTENDED NOR IMPLIED TO BE A SUBSTITUTE FOR PROFESSIONAL MEDICAL ADVICE. YOU SHOULD ALWAYS SEEK THE ADVICE OF YOUR PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROVIDER